Good news | Mednovo Group was recognized as an innovative SMEs

2022-11-03 17:46

Recently

Industry and Information Technology Department of JIANGSU announced

The 2023 Innovative SEMS to be identified list

Mednovo Group Co., Ltd

Be selected successfully

According to the policy , innovative SEMS have a higher level of specialization, strong innovation ability and development potential, and are the basic force of high-quality SEMS.

This recognition is the recognition by government departments at all levels that Mednovo Group has a high level of specialization, strong innovation ability and development potential, and will further promote the progress of the Group in the field of independent innovation and independent research and development, and encourage the Group to further enhance its core competitiveness and enhance the power of innovation and development.

In November 2020, the headquarters of Mednovo Group Co., Ltd officially settled in SND(Suzhou New District). The Group has set up a number of medical device projects in the mode of "self-research + acquisition + equity".The business of the group covers four major business clusters of heart and peripheral vascular, tumor mini-invasive, brain science, and women’s health,and has initially established an internationally advanced R & D, production and operation system, forming the Group's industrial technology strategy.

In the future, Adhering to independent innovation and quality, and taking the international approach, through in-depth integration with industrial needs, the group is committed to the R & D and provision of safe, effective and inclusive medical products and services. We work to progressively secure a world-leading position in related segment fields,create more substitution products, and further boost the growth of mini-invasive intervention in China.